Skip to main content
. Author manuscript; available in PMC: 2020 Mar 1.
Published in final edited form as: J Allergy Clin Immunol. 2019 Jan 9;143(3):894–913. doi: 10.1016/j.jaci.2019.01.003

FIG 8.

FIG 8.

A model of barrier disruption and skin sensitization. Allergens, infections, and tissue damage can stimulate release of TSLP, IL-33, and IL-25 from the epithelium. These epithelial cell–derived cytokines license dendritic cells (DCs) to drive type 2 responses but also act on a variety of cell types, including basophils, eosinophils, MCs, and innate lymphoid cells, to initiate and maintain allergic inflammation.128